
News|Articles|February 26, 2025
Advanced LC-MS Technology for Enhanced HCP Detection in Complex Biotherapeutics
Author(s)Samsung Biologics
The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Jubilant Biosys Announces New Facility in India
2
Pharmaceutical Supply Chain Resilience in a Shifting Market
3
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
4
Building the Foundations for Proactive Drug Safety in 2026
5